[Clinical outcomes research of Shuxuetong injection based on 59 287 cases in hospital information system]

Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(18):2714-7.
[Article in Chinese]

Abstract

Objective: In order to find out the condition of patients who used the Shuxuetong injection and provide reference and guidance for clinical practice, we analyzed the data of related indicators in patients in the HIS based of the frequency analysis methods.

Method: In this study, we selected the hospitalized patient information in 20 hospital information systems (HIS). Reference to the integrated data warehouse build mode, including some information such as age, gender, cost categories of patients, route of administration etc.

Result: The average age of patients are 59-years-old , 56-years-old age and 71-years-old age are the two high peaks during the age distribution. Patients covered by health insurance accounted for 75.8%; Intravenous infusion in patients accounted for 95.76%; Patient are also diagnosed as cardiovascular and cerebrovascular diseases, such as hypertension, cerebral infarction, coronary heart diseas, combined with other medicines such as aspirin, insulin, heparin etc.

Conclusion: Crowd using Shuxuetong injection mostly in the elderly population, most patients covered by health insurance, the route of administration conforms instructions basically, please attention the benefits and risks of the patients in the clinical practice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child, Preschool
  • Clinical Trials as Topic
  • Drug Therapy*
  • Drugs, Chinese Herbal / administration & dosage
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Hospital Information Systems
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care*
  • Young Adult

Substances

  • Drugs, Chinese Herbal
  • shuxuetong